-
Precursors to Empowering QARA Professionals with AI-Driven Technologies
Apr 18 | Clinical Research News | As life sciences companies increasingly embrace artificial intelligence and digital transformation, quality assurance and regulatory affairs professionals face opportunities and challenges. The journey from paper-based systems to AI-driven solutions requires careful consideration of the various factors required to ensure successful implementation while maintaining global compliance and product quality to ensure the provision of safe and effective patient solutions and treatments. More -
Vision Set for Integration of Research and Healthcare in Sweden
Apr 15 | Clinical Research News | Understanding the trajectory of a disease, including how it developed in the first place, is a bit like reconstructing a crime scene where scientists piece together fragmented information in hopes of mapping out the sequence of events and identifying the culprit. But critical connections can be made by analyzing multi-omics data linked to disease and registry data and turning them into actionable insights at the point of care. More -
Feasibility: The Art of Being Less Wrong, Faster
Apr 11 | Clinical Research News | Clinical trial complexity is at an all-time high, with today’s clinical trials being more complex in their design and execution, whilst also demanding more sophisticated data management, regulatory navigation, and operational coordination than trials conducted a decade ago. More -
Veradigm Powering Up Research with Real-World Cardiometabolic Datasets
Apr 10 | Clinical Research News | As a longtime electronic health record (EHR) supplier for ambulatory care providers, Veradigm (formerly Allscripts) finds itself at the “intersection of research and patient care” with the wherewithal to offer medical practitioners research opportunities and clinical trial sponsors real-world data and solutions to support their R&D ambitions. More -
The Scope of Things: AI Translating Clinical Trial Results, Improving Study Access, Aspirin Preventing Cancer Spread, More
Apr 09 | Clinical Research News | This month’s episode of the Scope of Things covers the latest news on setting expectations for Phase II cancer trials, insights about dementia from the Nun Study, and more, brought to you by host Deborah Borfitz. Ravi Parikh, medical director of data and technology applications shared resource at Winship Cancer Institute of Emory University, joins in to discuss TrialTranslator. More -
Simplicity and Standards are the Starting Points for Pragmatic Trials
Apr 03 | Clinical Research News | Pragmatic trials, by name, have been around for well over a decade now and, while well intentioned, they remain poorly understood and currently offer a limited value proposition to study sponsors and contract research organizations. More -
Withings Moves Beyond BMI with New Body Composition Scale
Apr 02 | Clinical Research News | Body Mass Index (BMI) is a long-used method to measure body fat with the formula kg/m2 (or lbs/in2 x 703 for imperial measurements). While it is a noninvasive and inexpensive way to measure body fat, there are arguments that BMI is inaccurate because it does not include other factors such as fat distribution, muscle mass, and metabolic health. More -
Challenges and Opportunities for Advancing Health Systems Across Africa: An Activist’s Perspective
Mar 28 | Clinical Research News | Marieme Ba, CEO of Pharmalys, discusses the underrepresentation of African countries in clinical research. Study protocols she worked on referenced continents, except Africa. Other African countries were occasionally included in clinical trials for infectious diseases, but for the most part, the continent was overlooked. This begs the question: why is Africa not represented? More -
DiMe Launches Resources Suite, Pistoia Alliance Reducing Carbon Footprint, More
Mar 27 | Clinical Research News | Digital Health Measurement Collaborative Community by the Digital Medicine Society released a suite of resources designed to effectively demonstrate the value of using digital endpoints in clinical trials; The Pistoia Alliance launched the next phase of its project to measure and reduce the carbon footprint of clinical trials; and more. More -
Follow the Money: Eikon Advances Multiple Programs, Multi-Payload Antibody-Drug Conjugate, More
Mar 26 | Clinical Research News | Eikon will advance its programs aimed to treat advanced melanoma, as well as breast, ovarian, prostate, pancreatic, and brain cancers; Callio launches with innovative multi-payload programs designed to maximize therapeutic benefit for cancer patients; and more. More


The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.